Trial Profile
Perioperative Levetiracetam for seizure prophylaxis in brain tumor patients. Prospective evaluation of side effects and efficacy .
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 05 Sep 2022
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Seizures
- Focus Therapeutic Use
- 03 Sep 2022 Status changed from recruiting to discontinued.
- 08 Mar 2016 New trial record